Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
obstructive sleep apnea
Biotech
Takeda stops phase 2 post-anesthesia trial over slow enrollment
Stopping the phase 2 danavorexton trial because of slow enrollment marked another twist in the development of the orexin-2 receptor agonist franchise.
Nick Paul Taylor
Oct 31, 2024 5:29am
FDA clears Withings' contactless mat for diagnosing sleep apnea
Sep 10, 2024 10:00am
Samsung scores FDA OK for smartwatch sleep apnea feature
Feb 12, 2024 11:49am
FDA OKs Vivos Therapeutics’ oral devices for severe sleep apnea
Nov 29, 2023 2:11pm
ResMed acquires diagnostics software maker Somnoware
Jul 6, 2023 10:17am
FDA label update eases access to Inspire's sleep apnea implant
Jun 13, 2023 11:26am
